GuidelineClinical infectious diseases : an official publication of the Infectious Diseases Society of America2026

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness.

Adarsh Bhimraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.